Prevention of naphthalene-induced cataract and hepatic glutathione loss by the L-cysteine prodrugs, MTCA and PTCA

Experimental Eye Research

Volumn 62, Issue 4, 1996, Pages 433-442

  Rathbun, William B ^a   Nagasawa, Herbert T ^a,b   Killen, Christina E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cataract prevention; Cysteine; Cysteine prodrugs; Glutathione; Lens; Liver; Thiazolidine

Indexed keywords

2 METHYL 4 THIAZOLIDINECARBOXYLIC ACID; 2 PROPYL 4 THIAZOLIDINECARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; CYSTEINE; NAPHTHALENE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029892222     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0048     Document Type: Article

References (26)

1. Gander, J. E., Sethna, S. S. and Rathbun, W. B. (1983). Bovine lens γ-glutamylcysteine synthetase: inhibition by glutathione and adenine nucleotides. Eur. J. Biochem. 133, 635-40.
2. Gifford, H. (1932). Determination of the oxidation-reduction mechanism in the lens of rabbits with naphthalene cataract. Arch. Ophthal. 7, 763-8.
3. Harper, A. E. (1970). Effects of ingestion of disproportionate amounts of amino acids. Physiol. Rev. 50, 428-558.
4. Holleschau, A. M., Rathbun, W. B. and Nagasawa, H. T. An HPLC radiotracer method for assessing the ability of L-cysteine prodrugs to maintain glutathione levels in the cultured rat lens. Curr. Eye Res. in press.
5. Koch, H.-R., Doldi, K. and Hockwin, O. (1976). Naphthalene cataracts in rats. Association of eye pigmentation and cataract development. Doc. Ophthal. Proc. Ser. 8, 293-303.
6. Mårtensson, J., Steinherz, R., Jain, A. and Meister, A. (1989). Glutathione ester prevents buthionine sulfoximine-induced cataract and lens epithelial cell damage. Proc. Natl. Acad. Sci., USA 86, 8727-31.
7. Nagasawa, H. T., Goon, D. J. W., Muldoon, W. P. and Zera, R. T. (1984). 2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity. J. Med. Chem. 27, 591-6.
8. Nagasawa, H. T., Goon, D. J. W. and Zera, R. T. (1982). Prodrugs of L-cysteine as liver-protective agents. 2(RS)-Methylthiazolidine-4(R)-carboxylic acid, a latent cysteine. J. Med. Chem. 25, 489-91.
9. Pirie, A. (1968). Pathology in the eye of the naphthalene-fed rabbit. Exp. Eye Res. 7, 354-7.
10. Rathbun, W. B. and Murray, D. L. (1991). Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens. Exp. Eye Res. 53, 205-12.
11. Roberts, J. C. and Francetic, D. J. (1991a). Mechanisms of chemoprotection by RibCys, a thiazolidine prodrug of L-cysteine. Med. Chem. Res. 1, 213-19.
12. Roberts, J. C. and Francetic, D. J. (1991b). Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys. Tox. Let. 59, 245-51.
13. Roberts, J. C., Nagasawa, H. T., Zera, R. T., Fricke, R. F. and Goon, D. J. W. (1987). Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids. J. Med. Chem. 30, 1891-6.
14. Schubert, M. P. (1935). Combination of thiol acids with methylglyoxal. J. Biol. Chem. 111, 671-8.
15. Schubert, M. P. (1936). Compounds of thiol acids with aldehydes. J. Biol. Chem. 114, 341-50.
16. Schubert, M. P. (1939). The combination of cysteine with sugars. J. Biol. Chem. 130, 601-3.
17. Shichi, H., Tanaka, M., Jensen, N. M. and Nebert, D. W. (1980). Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacol. 20, 229-41.
18. Tao, R. V., Holleschau, A. M. and Rathbun, W. B. (1991). Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes. Ophthal. Res. 23, 272-83.
19. Van Heyningen, R. and Pirie, A. (1967). The metabolism of naphthalene and its toxic effect on the eye. Biochem. J. 102, 842-52.
20. Van Heyningen, R. (1979). Naphthalene cataract in rats and rabbits: a resumé. Exp. Eye Res. 28, 435-9.
21. Wegener, A. and Hockwin, O. (1987). Animal models as a tool to detect the subliminal cocataractogenic potential of drugs. In Concepts in Toxicology (Ed. Homburger, F.), Vol. 4, Pp. 250-62. Karger: Basel.
22. Wells, P. G., Wilson, B. and Lubek, B. M. (1989). In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Tox. Appl. Pharmacol. 99, 466-73.
23. Wlodek, L., Wróbel, M. and Czubak, J. (1992). Transamination and transsulfuration of L-cysteine in Ehrlich ascites tumor cells and mouse liver. The non-enzymatic reaction of L-cysteine with pyruvate. Int. J. Biochem. 25, 107-12.
24. Xu, G.-T., Zigler, J. S. and Lou, M. F. (1992a). The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (AL)1576. Exp. Eye Res. 54, 63-72.
25. Xu, G.-T., Zigler, J. S. and Lou, M. F. (1992b). Establishment of a naphthalene cataract model in vitro. Exp. Eye Res. 54, 73-81.
26. Zhao, C. and Shichi, H. (1995). Immunocytochemical study of cytochrome P450 (1A1/1A2). Induction in murine ocular tissues. Exp. Eye Res. 60, 143-52.